Home » Topics » BioWorld

BioWorld
RSS

MORE FUNDS FOR HIV VACCINE

May 15, 1992

CHIRON'S ROBOTIC PEPTIDE BUILDER

May 15, 1992

GENENTECH HUMANIZES CANCER MAB

May 15, 1992

SECOND REDUCED IPO OF THE WEEK

May 15, 1992

ALKERMES PATENT ON BBB COMPOUNDS

May 15, 1992

SERAGEN PLANS MORE FUSION TOXIN TRIALS

May 14, 1992

THERATECH BRAVES THE IPO MARKET

May 14, 1992

SYNERGEN-SYNTEX BEGINS ALS TRIALS

May 14, 1992

$180 MILLION SCIOS-NOVA MERGER DEAL

May 14, 1992

DIFFERENT INTERPRETATIONS OF IMNR RESULTS

May 14, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.